These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2846928)

  • 1. [A new determination method of type IV collagen in sera and its clinical significance in relation to hepatic fibrosis].
    Suzuki H; Suzuki M; Kato Y; Okabe K; Uchikoshi T
    Nihon Shokakibyo Gakkai Zasshi; 1988 Aug; 85(8):1569. PubMed ID: 2846928
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatic fibrosis and its serum markers].
    Okabe K
    Rinsho Byori; 1992 Dec; 40(12):1258-64. PubMed ID: 1339165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate therapy and liver fibrosis: are human prolyl hydroxylase and type IV collagen reliable and sensitive markers?
    Tamaro G; Danek GM; Mangiarotti MA; Tamaro P; Zanazzo GA
    Int J Clin Lab Res; 1995; 25(1):55. PubMed ID: 7787212
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of serum 7S collagen in various liver diseases.
    Yamada S; Suou T; Kawasaki H; Yoshikawa N
    Clin Biochem; 1992 Dec; 25(6):467-70. PubMed ID: 1335851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of interferon therapy on fibrosis serum markers in HCV-positive chronic liver disease.
    Mazzoran L; Tamaro G; Mangiarotti MA; Marchi P; Baracetti S; Gerini U; Fanni-Cannelles M; Zorat F; Pozzato G
    Eur J Gastroenterol Hepatol; 1998 Feb; 10(2):125-31. PubMed ID: 9581987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis.
    Fabris C; Falleti E; Federico E; Toniutto P; Pirisi M
    Ann Clin Biochem; 1997 Mar; 34 ( Pt 2)():151-5. PubMed ID: 9133247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of the determination of serum immunoreactive prolyl hydroxylase (SIRPH) in hepatic fibrosis].
    Suzuki H; Suzuki M; Okabe K; Uchikoshi T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1265-71. PubMed ID: 2822984
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?
    Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differences in changes of two serum markers of hepatic fibrogenesis in acute hepatitis].
    Matsuda Y; Yasuhara M; Takada A
    Nihon Shokakibyo Gakkai Zasshi; 1987 Aug; 84(8):1631-8. PubMed ID: 2826851
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activity diagnosis of liver fibrosis and liver cirrhosis].
    Langness U
    Med Klin; 1977 Mar; 72(12):492-6. PubMed ID: 190524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assay of serum collagen markers in chronic liver diseases and liver cancer].
    Inoue T; Funaki N; Hatahara T; Igarashi S; Kaneko E; Tanaka H
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1506-13. PubMed ID: 2170716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
    Pereira TN; Lewindon PJ; Smith JL; Murphy TL; Lincoln DJ; Shepherd RW; Ramm GA
    J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is serum prolyl 4-hydroxylase useful as noninvasive marker of liver fibrosis in patients with biliary atresia?
    Kobayashi H; Tamura T; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2005 Aug; 40(8):1366-7. PubMed ID: 16080952
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis.
    Murawaki Y; Ikuta Y; Nishimura Y; Koda M; Kawasaki H
    J Gastroenterol Hepatol; 1996 May; 11(5):443-50. PubMed ID: 8743916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The slow progression of hepatic fibrosis in intrahepatic cholestasis as compared with extrahepatic biliary atresia.
    Shirahase I; Ooshima A; Tanaka K; Inamoto T; Yamamoto E; Ozawa K; Yamabe H
    Eur J Pediatr Surg; 1995 Apr; 5(2):77-81. PubMed ID: 7612587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of measurement of PIIIP, laminin P1, type IV-C and 7S in patients with chronic liver diseases--with special reference to histological findings].
    Sato S
    Nihon Shokakibyo Gakkai Zasshi; 1992 Sep; 89(9):2007-15. PubMed ID: 1404988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of serum prolyl hydroxylase beta-subunit levels determined using monoclonal antibody].
    Yasuhara M; Matsuda Y; Takada A
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1225-32. PubMed ID: 2822982
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of serum markers of fibrosis by levels of circulating intercellular adhesion molecule-1 in acute and chronic liver disease.
    Fabris C; Pirisi M; Falleti E; Soardo G; Gonano F; Bartoli E
    Clin Biochem; 1994 Oct; 27(5):407-12. PubMed ID: 7867219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum type IV collagen and prolyl hydroxylase levels: effect of gender and age.
    Tamaro G; Moretti M; Marchi P; Mangiarotti M; Pozzato G
    Clin Chim Acta; 1994 Aug; 228(2):205-10. PubMed ID: 7988036
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of prolyl hydroxylase analysis in clinical tests].
    Yamada S; Kawasaki H
    Nihon Rinsho; 1989 Dec; 48 Suppl():321-3. PubMed ID: 2560079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.